-transparent.png){kind=logo}
Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo. 1998
Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Fairfield, Victoria 3078, Australia.
Ducks congenitally infected with duck hepatitis B virus (DHBV) were treated with the antiviral guanine nucleoside analog penciclovir for 12 or 24 weeks at a dosage of 10 mg/kg of body weight per day. By the completion of both 12 and 24 weeks of therapy, molecular hybridization studies of the liver tissue revealed that the viral DNA, RNA, and protein levels were significantly reduced compared to those in the placebo-treated controls. Penciclovir treatment for 12 or 24 weeks was not associated with any toxicity, establishing the efficacy and safety of long-term penciclovir therapy in chronic DHBV infection.
Related Publications
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
December 1996,
Zeitschrift fur Gastroenterologie,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
January 2011,
Przeglad epidemiologiczny,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
April 1994,
Antimicrobial agents and chemotherapy,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
January 1996,
Methods in molecular medicine,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
July 1993,
Antimicrobial agents and chemotherapy,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
August 1996,
Antiviral therapy,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
January 2015,
Therapeutics and clinical risk management,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
January 2013,
Antiviral therapy,
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
March 1999,
Hepatology (Baltimore, Md.),
E Lin, and
C Luscombe, and
D Colledge, and
Y Y Wang, and
S Locarnini
January 2011,
Annals of hepatology,
